BioPlus is a family majority owned business with over 500 employees, multiple manufacturing sites and business in over 50+ countries. Our products are focused on naturally sourced, renewable resource compounds validated by advanced science. Our focus is on licensed and OTC (nutritional) pharmaceuticals or healthcare products, novel drug delivery, excellence in carbohydrate chemistry and biopharmaceuticals.
In 2008, AIF Capital a leading private equity fund invested in BioPlus Life Sciences to support an ambitious growth plan.
Our 60+ years of tradition, trust and reliability is supported by our desire to look further, take a long-term view and be flexible in our understanding of changing needs. Our challenge in the next millennium remains to focus successfully on meeting the aspirations of our employees and our customers, whilst balancing our increasingly research driven environment. Our only competitive advantage remains to "Think Ahead" whilst not forgetting our humble past. Thank you for allowing us to share our future with you.
BioPlus Life Sciences is a research driven company, continually evolving and aspires to improve products and service quality through the utilization of the latest technology...
BioPlus's technology for manufacturing sucralose is thus the only alternative novel process that has achieved the specifications of International Standard equal to that of Tate...
BioPlus Life Sciences co-exhibited with Natures Only, USA at the Vitafoods Europe 2016, May 10 – 12, 2016, Palexpo, Geneva, Switzerland. Vitafoods happens to be a global nutraceutical event, which focusses on herbal APIs, natural products, nutraceuticals and dietary supplements etc.
BioPlus Life Sciences participated the Vitafoods Europe 2015 held at Geneva from May 05 to May 07, 2015. Vitafoods happens to be a global nutraceutical event which focusses on herbal APIs, Natural Products, Nutraceuticals and Dietary Supplements etc.